Science · Open for opinions
Will the FDA announce approval or regulatory advancement of an ocular optogenetic gene therapy by November 30, 2026?
Consider official FDA regulatory announcements regarding optogenetic therapies between October 10 and November 30, 2026. 79 opinions, 65% No
- Yes — 35%
- No — 65%
Deadline: November 30, 2026 at 11:59 PM UTC · 79 opinions
Resolution rules
Consider official FDA regulatory announcements regarding optogenetic therapies between October 10 and November 30, 2026.
Source: www.sciencenews.org
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 10/10/2026 (00:00, horário de Brasília) até 30/11/2026 (23:59). Fatos, anúncios ou eventos anteriores ao início da janela não contam. Resolve como 'Sim' se a Food and Drug Administration (FDA) dos EUA publicar em seu portal oficial (fda.gov) aprovação, autorização de IND ou designação especial para terapia gênica baseada em optogenética para visão até 30/11/2026. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 65% of the votes: an opinion on it that turns out right earns about 35 points, a wrong one costs about 65.